News from the FDA/CDC
News
FDA approves biosimilar to bevacizumab
Bevacizumab-awwb is approved for the treatment of adults with certain colorectal, lung, brain, kidney, and cervical cancers.
News from the FDA/CDC
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod
The recombinant herpes zoster vaccine delivered 91% efficacy in patients aged 70 years and older.
News
FDA advisory committee rejects opioids in children’s cough syrup
Adolescents are the most at-risk population for opioid misuse.
News from the FDA/CDC
Sleep issues vary by menopausal status
Report examines sleep duration and quality in women aged 40-59 years.
News from the FDA/CDC
Recent upturn seen in stroke death rate
Long-term decline ended in 2013; reasons for the reversal “are not clear.”
News from the FDA/CDC
Zika’s 2017 summer less active than 2016
Warmer weather did not bring about an increase in activity.
News
Austedo approved for treatment of tardive dyskinesia
The drug was also approved in April 2017 to treat chorea associated with Huntington’s disease.
News from the FDA/CDC
Young adults lead the ranks of recently insured
Since 2010, Americans aged 18-29 years have seen a larger drop in their uninsured rate than those younger and older.
News
Extended-release amantadine approved for treatment of dyskinesia in Parkinson’s
This is the first FDA approval for a drug to treat levodopa therapy-related dyskinesia in patients with Parkinson’s disease.
News from the FDA/CDC
Safety issues not that unusual in medical offices
Pharmacies may correct or clarify prescriptions, and lab results aren’t ready when needed.
News
FDA approves first spironolactone oral suspension
After more than 50 years on the U.S. market, spironolactone is available in liquid form, bypassing the compounding pharmacist.